Literature DB >> 30791234

Construction of a Model Culture System of Human Colonic Microbiota to Detect Decreased Lachnospiraceae Abundance and Butyrogenesis in the Feces of Ulcerative Colitis Patients.

Kengo Sasaki1, Jun Inoue2, Daisuke Sasaki1, Namiko Hoshi2, Tomokazu Shirai3, Itsuko Fukuda1, Takeshi Azuma2, Akihiko Kondo1,3, Ro Osawa4,5.   

Abstract

Compositional alteration of the gut microbiota is associated with ulcerative colitis (UC). Here, a model culture system is established for the in vitro human colonic microbiota of UC, which will be helpful for determining medical interventions. 16S ribosomal RNA sequencing confirms that UC models are successfully developed from fecal inoculum and retain the bacterial species biodiversity of UC feces. The UC models closely reproduce the microbial components and successfully preserve distinct clusters from the healthy subjects (HS), as observed in the feces. The relative abundance of bacteria belonging to the family Lachnospiraceae significantly decreases in the UC models compared to that in HS, as observed in the feces. The system detects significantly lower butyrogenesis in the UC models than that in HS, correlating with the decreased abundance of Lachnospiraceae. Interestingly, the relative abundance of Lachnospiraceae does not correlate with disease activity (defined as partial Mayo score), suggesting that Lachnospiraceae persists in UC patients at a decreased level, irrespective of the alteration in disease activity. Moreover, the system shows that administration of Clostridium butyricum MIYAIRI restores butyrogenesis in the UC model. Hence, the model detects deregulation in the intestinal environment in UC patients and may be useful for simulating the effect of probiotics.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  butyrate; microbiota; model culture systems; probiotics; ulcerative colitis

Mesh:

Substances:

Year:  2019        PMID: 30791234     DOI: 10.1002/biot.201800555

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  15 in total

Review 1.  The Kobe University Human Intestinal Microbiota Model for gut intervention studies.

Authors:  Namiko Hoshi; Jun Inoue; Daisuke Sasaki; Kengo Sasaki
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-15       Impact factor: 4.813

2.  Bacillus coagulans SANK 70258 suppresses Enterobacteriaceae in the microbiota of ulcerative colitis in vitro and enhances butyrogenesis in healthy microbiota.

Authors:  Kengo Sasaki; Daisuke Sasaki; Jun Inoue; Namiko Hoshi; Takayuki Maeda; Ryouichi Yamada; Akihiko Kondo
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-07       Impact factor: 4.813

Review 3.  The Controversial Role of Human Gut Lachnospiraceae.

Authors:  Mirco Vacca; Giuseppe Celano; Francesco Maria Calabrese; Piero Portincasa; Marco Gobbetti; Maria De Angelis
Journal:  Microorganisms       Date:  2020-04-15

4.  Butyryl-CoA:acetate CoA-transferase gene associated with the genus Roseburia is decreased in the gut microbiota of Japanese patients with ulcerative colitis.

Authors:  Ryohei Shinohara; Kengo Sasaki; Jun Inoue; Namiko Hoshi; Itsuko Fukuda; Daisuke Sasaki; Akihiko Kondo; Ro Osawa
Journal:  Biosci Microbiota Food Health       Date:  2019-06-26

5.  In Situ Profiling of the Three Dominant Phyla Within the Human Gut Using TaqMan PCR for Pre-Hospital Diagnosis of Gut Dysbiosis.

Authors:  Young Jae Jo; Setu Bazie Tagele; Huy Quang Pham; YeonGyun Jung; Jerald Conrad Ibal; SeungDae Choi; Gi-Ung Kang; Sowon Park; Yunkoo Kang; Seung Kim; Hong Koh; Jae-Ho Shin
Journal:  Int J Mol Sci       Date:  2020-03-11       Impact factor: 5.923

6.  Bifidogenic and butyrogenic effects of young barely leaf extract in an in vitro human colonic microbiota model.

Authors:  Daisuke Sasaki; Kengo Sasaki; Yasushi Kadowaki; Yasuyuki Aotsuka; Akihiko Kondo
Journal:  AMB Express       Date:  2019-11-13       Impact factor: 3.298

7.  A diet high in sugar and fat influences neurotransmitter metabolism and then affects brain function by altering the gut microbiota.

Authors:  Yinrui Guo; Xiangxiang Zhu; Miao Zeng; Longkai Qi; Xiaocui Tang; Dongdong Wang; Mei Zhang; Yizhen Xie; Hongye Li; Xin Yang; Diling Chen
Journal:  Transl Psychiatry       Date:  2021-05-27       Impact factor: 6.222

8.  W27 IgA suppresses growth of Escherichia in an in vitro model of the human intestinal microbiota.

Authors:  Kengo Sasaki; Tomoyuki Mori; Namiko Hoshi; Daisuke Sasaki; Jun Inoue; Reiko Shinkura; Akihiko Kondo
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

9.  Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis.

Authors:  Mengmeng Li; Congya Li; Xianan Wu; Tangtian Chen; Lei Ren; Banglao Xu; Ju Cao
Journal:  Crit Care       Date:  2020-05-27       Impact factor: 9.097

10.  Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model.

Authors:  Irfan A Rather; Vivek K Bajpai; Lew L Ching; Rajib Majumder; Gyeong-Jun Nam; Nagaraju Indugu; Prashant Singh; Sanjay Kumar; Nahid H Hajrah; Jamal S M Sabir; Majid Rasool Kamli; Yong-Ha Park
Journal:  Saudi J Biol Sci       Date:  2019-09-04       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.